PharmacoCorp, a multinational pharmaceutical company, sources raw materials from various suppliers across three continents to manufacture a novel drug, \"VitaPlus.\" Each supplier uses a different data management system, and the manufacturing process involves several stages, each tracked by a separate internal system. VitaPlus is subject to stringent regulatory requirements, including the need to demonstrate the authenticity and integrity of all data related to its production and distribution. A recent audit revealed inconsistencies in the reported origin and processing steps of certain raw material batches. This raised concerns about potential data manipulation and regulatory non-compliance.\n\nConsidering the challenges PharmacoCorp faces in ensuring data quality across its complex supply chain and the critical need to comply with regulatory requirements, which dimension of data quality is MOST crucial for addressing the identified issues and enabling effective auditing and accountability?